7 abril 2015
Cancer researchers have identified a key signaling pathway in B-cell lymphoma, a malignant type of blood cancer. They demonstrate that the signaling pathway can be blocked using compounds that are already in clinical development. This finding might be extremely important for the diagnosis, prognosis and treatment of this disease in the future, researchers say.
http://feeds.sciencedaily.com/~r/sciencedaily/~3/Bj6Na8lSLl8/150407084854.htm
